J&J Vaccine Study to Resume in South Africa on Wednesday, Ministry Says: A research study in South Africa further evaluating Johnson & Johnson’s COVID-19 vaccine in the field will resume on Wednesday, the health ministry said, after the study was paused over rare cases of …
Source: “South Africa” – BingNews
Single dose of J&J’s Ad26.COV2.S vaccine effective against SARS-CoV-2 including in South Africa variant: One of these vaccines, the Ad26.COV2.S vaccine by Johnson & Johnson and Janssen, is a recombinant, replication-incompetent human adenovirus type 26 vector that encodes full-length SARS-CoV-2 spike …
Source: “South Africa” – BingNews
Pegasus Europe announces key terms and intended listing on Euronext Amsterdam: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION …
Source: “South Africa” – BingNews
